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INTRODUCTION
A wide variety of conditions may result in pericardial effusion. The etiologic spectrum in 
different series largely depends on the source of the patients, the characteristics of the centre, 
and on the frequency distribution of the different etiologies in each geographic area. In many 
cases, pericardial effusion is associated with a previous known condition or underlying cardiac 
diseases, which are finally proven to be the cause of the pericardial effusion. In patients with no 
apparent cause of pericardial effusion, the presence of inflammatory signs are predictive of 
acute (idiopathic) pericarditis; on the other hand, sever effusion with absence of tamponade is  
predictive of chronic idiopathic pericardial effusion. Tamponade without inflammatory signs is 
suspicious for neoplastic pericardial effusion. The prognosis of pericardial effusion is related to 
the underlying disease, being especially poor in patients with malignancy.
The series by Colombo etal included 25 male patients, all of whom were submitted to an 
invasive pericardial procedure. Of these patients, 44% presented with cardiac tamponade. The 
most  frequent  causes of  pericardial  effusion were:  neoplastic  (36%),  idiopathic (32%),  and 
uremic (20%).
 Corey etal  investigated the etiology of pericardial  effusion in 57 patients.  Etiologic 
diagnosis  was  made  in  53patients  (93%).  The  most  common  diagnoses  were  malignancy 
(23%), viral infection (14%), radiation induced inflammation (14%), collagen –vascular disease 
(12%), and uremia (12%). In only four patients there was no diagnosis made.
 Sagrista –Sauleda etal included 322 patients, 132 with moderate and 190 with severe 
pericardial effusion. Cardiac tamponade was present in 37%. In this series, the most common 
diagnosis was acute idiopathic pericarditis which accounted for 20% of patients. The next most 
prevalent diagnoses were iatrogenic effusion (16%), neoplastic effusion (13%), and chronic 
idiopathic pericardial effusion (9%).
In the 56 patients with tamponade included in the study of Guberman etal, the most 
common  diagnoses  were  metastatic  cancer  in  18  patients,  idiopathic  pericarditis  in  eight 
patients, and uremia in five. Once again, the worst prognosis was in the group of patients with  
cancer.  
Study by Levine etal, involving 50 patients, the most frequent etiologies of pericardial 
effusion were malignancy (58%), idiopathic effusion (14%), and uremia (14%).
 In a consecutive series by Blake S etal of 32 cases of chronic constrictive pericarditis 
four patients were attributable to rheumatoid disease, two patients to trauma, one patient to 
sarcoidosis, and four patients to tuberculosis. In the remaining 21 cases the etiology was not 
found. Therefore the main causes of large pericardial effusion in general medical centres are 
idiopathic pericarditis and malignancy. 
CLINICAL CLUES TO ETIOLOGY:     
Agner and Gallis, in a retrospective series of 133 patients, observed that hemodynamic 
compromise, cardiomegaly, pleural effusion, and large pericardial effusion were more common 
in patients with Tuberculous or malignant disease than in patients with idiopathic pericarditis. 
In the series of Posner etal, dealing with 31 patients with cancer and pericardial disease, 
patients with malignant pericardial disease had tamponade more frequently, whereas fever, a 
pericardial  friction  rub,  and  improvement  following  treatment  with  non-steroidal  anti-
inflammatory drugs characterized patients with idiopathic pericarditis. The predictive value of 
these  different  clinical  findings  for  assessing  the  etiology  of  pericardial  effusion  was  not 
established.
 Recent prospective study of 322 patients with moderate and severe pericardial effusion, 
investigated the value of selected clinical, data (underlying disease, development of cardiac 
tamponade, and presence or absence of inflammatory signs) for inclusion of the patients in a 
likely major etiologic diagnostic category. In 60% of the patients a known previous condition 
that could cause pericardial effusion was present. The pericardial effusion was shown to be 
related to the underlying disease in all  but seven of these patients.  In the patients with no 
apparent cause of pericardial effusion, the presence of inflammatory signs (characteristic chest 
pain, pericardial friction rub, fever or typical electrocardiography changes) were predictive for 
acute idiopathic pericarditis (p<0.001, likelihood ratio 5.4), irrespective of the size of effusion 
and  presence  or  absence  of  tamponade.  Furthermore,  a  large  effusion  with  absence  of 
inflammatory signs and absence of tamponade was predictive of chronic idiopathic pericardial 
effusion  (p<0.001,  likelihood  ratio  20),  and  tamponade  without  inflammatory  signs  was 
predictive of neoplastic pericardial effusion (p<0.001, likelihood ratio 2.9).
The diagnosis can be established through general examination, including the search of 
tubercle bacilli in sputum or gastric aspirate (which provided the diagnosis in four of our eight  
cases), or by means of pericardial fluid or pericardial tissue examination (indicated in patients 
pericarditis with tamponade or with persistent active illness for more than three weeks). 
Echocardiographic clues to etiology:
Band-like intrapericardial echoes and masses were initially described in the pericardial 
cavity in patients with pericardial effusion of varying etiology. In fact most of such patients  
were associated with malignancy. 
The intrapericardial abnormalities associated with tuberculous pericardial effusion were 
reported by Chia etal. He described linear frond-like echo dense structures protruding into the 
pericardial cavity forming a dense mass as a result of Fibrinous pericarditis.
 Liu  etal,  demonstrated  that  thickened  pericardium  and  fibrin  strands  were  highly 
specific (94% and 88% respectively), and exudative coating had a high sensitivity (100%), but 
low  specificity  (22%),  in  the  diagnosis  of  tuberculous  pericarditis.  The  thickness  of  the 
exudative coating/deposits by echocardiography was found to be 4.5 (2.0) mm in tuberculous 
pericardial effusion and 2.8 (0.69) mm in chronic idiopathic pericardial effusion (p<0.013). 
Intrapericardial  echo  abnormalities  such  as  a  greater  degree  of  pericardial  thickening,  and 
thickness of exudative coating or deposits, and strands crossing the pericardial space, are useful 
in  the  diagnosis  of  tuberculous  pericardial  effusion  and  in  differentiating  this  entity  from 
chronic idiopathic pericardial effusion. 
As there are wide variations in etiology of chronic pericardial diseases, we did a research 
mainly to findout the etiological profile of chronic pericardial disease. This will be helpful in 
deciding the long term therapy in those patients. This also has prognostic implications.
REVIEW OF LITERATURE
Introduction:
Pericardium is specialized structure to serve its complex active and passive functions. 
The  pericardium is  composed  of  the  parietal  pericardium (an  outer  fibrous  layer)  and  the 
visceral pericardium (an inner serous membrane made of a single layer of mesothelial cells).  
The visceral pericardium is attached to the epicardial fat and reflects back on itself to form the  
parietal pericardium. The pericardium normally contains as much as 50 mL of an ultrafiltrate of 
plasma. Drainage occurs via the thoracic duct and the right lymphatic duct into the right pleural 
space.
Pericardial  physiology  includes  three  main  functions.  First,  through  its  mechanical 
function, the pericardium promotes cardiac efficiency by limiting acute dilation, maintaining 
ventricular  compliance with preservation  of  the  Starling  curve,  and distributing hydrostatic 
forces. The pericardium also creates a closed chamber with sub atmospheric pressure that aids 
atrial  filling  and  lowers  transmural  cardiac  pressures.  Second,  through  its  membranous 
function, the pericardium shields the heart by reducing external friction and acting as a barrier  
against  extension of infection and malignancy.  Third,  through its  ligamentous function,  the 
pericardium anatomically fixes the heart. 
It  contains  two types  of  sinuses.  The  transverse  sinus  lies  in  front  of  the  atria  and 
superior venae cavae and behind the proximal ascending aorta and pulmonary artery as a short 
pericardial passage. The  oblique sinus forms a separate recess with the pulmonary veins and 
forms an inverted "U", framing a posterior projection. CT and MRI disclose numerous smaller 
recesses. The pericardial sinuses and recesses increase the pericardial capacity to accommodate 
increased fluid (or other contents), contributing to the pericardial reserve volume. 
Virtually pericardium is involved in various diseases. Pericardial diseases have various 
clinical patterns. 
Clinical pericardial syndromes are:
 Acute pericarditis
 Relapsing pericarditis
 CardiacTamponade
 Chronic pericardial effusion without compression
 Effusive constrictive pericarditis
 Constrictive pericarditis
Some important causes of pericarditis:
Idiopathic
Infectious
Viral
Bacterial
Fungal
Parasitic
Immunological
Relapsing pericarditis
Post infarction (Dressler’s syndrome)
Post cardiotomy syndrome
Rheumatic fever
Still’s disease
Rheumatoid arthritis
Systemic lupus erythematosus (SLE)
Mixed connective tissue disease
Polyarteritis and the Churg-Strauss variant
Neoplastic
Post-irradiation
Traumatic
Uremic
Drug induced
Patterns of pericardial diseases
Viral pericarditis
Viral pericarditis is the most common infectious disease of the pericardium. It is caused 
by either direct viral attack, the immune response following the viral infection, or both.  
The following viruses are usually responsible for pericarditis.
 Enterovirus, 
 Adenovirus, 
 Cytomegalovirus (CMV), 
 Ebstein-barr virus, 
 Herpes simplex virus, 
 Influenza virus, 
 Parvo b19 virus,
 Hepatitis C virus, 
 HIV.
Initial presentation often resolves within two weeks. In up to 50% of patients it may 
recur.  It  may  present  with  acute  effusive  pericarditis;  tamponade,  constriction  and  “dry” 
pericarditis. Arrhythmias or conduction defects indicate the presence of associated myocarditis 
or  other  concomitant  heart  disease.  Evaluation  of  pericardial  effusion  and/or 
pericardial/epicardial tissue by polymerase chain reaction (PCR) or in situ hybridization may 
be helpful in arriving the etiology.  A fourfold rise in serum antiviral antibodies is suggestive 
but not diagnostic.
In  chronic  or  recurrent  symptomatic  pericardial  effusion  due  to  viral  infection,  the 
following specific treatment is under investigation 
(1) CMV pericarditis:
 Hyper immunoglobulin once daily, 
 4ml/kg intravenously on days 0, 4 and 8; 
 2ml/kg on day 12 and 16 
(2) Coxsackie B pericarditis
 Interferon alpha 2.5x106 IU/m2 subcutaneously three times a week
(3) Adenovirus and Parvo virus B19 positive Myocarditis
 Hyper immunoglobulin 10g IV on days 1and 3
Auto reactive pericarditis
It is characterized by recurrent episodes of pericardial effusion. It has following specific 
features. Pericardial fluid analysis revealed an increased number of  lymphocytes/mononuclear 
cells  >5000/mm3 (auto  reactive   lymphocytes),  or  the  presence  of  antibodies  against  heart 
muscle tissue in the pericardial fluid (auto reactive antibody mediated); (2) signs of myocarditis 
on epicardial/endomyocardial biopsies (≥14cells/mm2); (3) exclusion of active viral infection in 
pericardial  effusion  and  endomyocardial/  epimyocardial  biopsies  (no  virus  isolation,  no 
immunoglobulin IgM titre against cardio tropic viruses in pericardial effusion, and negative 
PCR   for  major  cardio  tropic  viruses);  (4)  tuberculosis,  Borrelia  burgdorferi,  Chlamydia 
pneumoniae, and other bacterial infection excluded by PCR and/or cultures; (5) no neoplastic 
infiltration  in   pericardial  effusion  or  tissue;  and  (6)  exclusion  of  uremia,  systemic,  and 
metabolic disorders.
Tuberculous pericarditis:
Tuberculous pericarditis can present with various clinical manifestations. It may present 
with acute pericarditis; chronic pericardial effusion without compression; Effusive-constrictive 
pericarditis;  Relapsing  pericarditis;  Cardiac  Tamponade  and  Constrictive  pericarditis. 
Pericardial  constriction  occurs  in  30-50%  of  cases  and  mortality  in  untreated  disease 
approaches 85%. The absolute criteria for diagnosis are the identification of mycobacterium 
tuberculosis in the pericardial fluid or tissue, and/or the presence of caseousgranulomas in the 
pericardium. Sputum cultures, ELISPOT skin test, analyses of pericardial effusion by acid-fast 
staining, mycobacterium culture or radiometric growth detection (for example, BACTEC -460), 
adenosinedeaminase (ADA) , pericardial lysozme, and PCR for M  tuberculosis are various 
modalities has been used for the diagnosis of Tuberculous pericarditis.  High ADA (> 40U/I) in 
pericardial effusion is diagnostic for Tuberculous pericarditis (93% sensitivity, 97% specificity) 
and it is a prognostic indicator for pericardial constriction. “PCR is as sensitive (75% v 83%), 
but more specific (100% v 78%) for Tuberculous pericarditis than ADA. 
Tuberculous pericarditis should be promptly treated with a combination of three or four 
tuberculostatic drugs for 9-12 months. In a study by Gooi HC etal forty-one patients with acute 
tuberculous  pericarditis  were  studied  retrospectively.  Anti-tuberculosis  chemotherapy  alone 
was effective  in  thirty  patients.  Five  patients  died,  two from unrelated  causes,  two due  to 
delayed diagnosis, and one after pericardiectomy. Constrictive pericarditis developed in seven 
patients, six of whom had successful pericardiectomy. Corticosteroids could not be shown to 
have reduced the risk of developing constriction. When constriction occurred it did so within 
the  first  six  months  of  illness  in  all  cases.  Prednisone  should  be  administered  along  with 
antituberculous drugs in relatively high initial doses (1mg/kg) and maintained for 5-7 days. It  
should be progressively reduced over the span of 6-8 weeks. Corticosteroids reduce the host 
reaction to mycobacterial infections, minimize exudation, fibrin deposition, and proliferation of 
tuberculomata,  may  decrease  symptoms  and  signs,  and  reduce  mortality  in  Tuberculous 
pericarditis.  If  symptoms and sings  of  constrictive  pericarditis  remain 6-8 weeks  after  full 
tuberculostatic and corticosteroid treatment, Pericardiectomy is indicated. 
Fungal pericarditis
Fungal  pericarditis  occurs  mainly  in  immunocompromised  patients  (Candida, 
Aspergillus,  Blastomyces,  Nocardia,  and Actinomyces species) or in the course of endemic 
fungal infections (Histoplasma, coccidioides).The clinical picture comprises the full spectrum 
of pericardial  diseases  including fungal  myocarditis.  Diagnosis  is  obtained by staining and 
culturing pericardial fluid or tissue, and antifungal antibodies in serum are also helpful.
Pericarditis in renal failure:
Uremic pericarditis
It is the Fibrinous inflammation with adhesions between the thickened pericardial 
membranes (“bread and butter” appearance) caused by the high degree of azotemia (blood urea 
nitrogen usually> 60mg/dl) in advanced renal failure before dialysis or shortly thereafter.
Dialysis associated pericarditis 
It occurs in patients on maintenance haemodialysis, and occasionally with chronic 
peritoneal  dialysis.  It  is  caused  by  inadequate  dialysis  and  /or  fluid  overload.  After  renal 
transplantation pericarditis may be caused by uremia or infections (for example, CMV)
Most  patients  with uremic pericarditis  respond within 1-2 weeks to  haemo-or 
peritoneal  dialysis.  Heparin-free  haemodialysis  should  be  used  to  avoid  intrapericardial 
hemorrhage.  Patients  with  pretamponade  should  undergo  pericardiocentesis  before 
haemodialysis  since  acute  fluid  removal  with  haemodialysis  can  lead  to  cardiovascular 
collapse. Peritoneal dialysis, is used if heparin-free haemodialysis cannot be performed. It can 
compromise respiratory function because of intraperitioneal fluid accumulation. Large, non-
resolving  symptomatic  effusions  should  be  treated  with  instillation  of  intrapericardial 
corticosteroids  (triamcinolone)  after  pericardiocentesis  or  subxiphoid  pericardiotomy. 
Pericardiectomy is indicated only in refractory, severely symptomatic patients.
Post –cardiac injury syndrome
Post–cardiac injury syndrome develops within days to months after cardiac/pericardial 
injury.   It  acutely  provokes  a  greater  antiheart  antibody  response  (antisarcolemmal  and 
antifibrillary antibodies). These antibodies appear to be pathogenic or may act in the presence 
of  a  dormant  or  concurrent  viral  infection.  Treatment  of  this  syndrome  is  based  on 
administration an NSAID or colchicines.
Pericarditis in myocardial infarction
Pericarditis may occur “early” (pericarditis epistenocardica) or be “delayed” (Dressler’s 
syndrome) after myocardial infarction. Epistenocardica pericarditis, caused by direct exudation, 
occurs in the first several days of almost half of transmural myocardial infarctions, although 
early thrombolytic treatment had decreased its incidence. Dressler’s syndrome occurs from one 
week  to  several  months  after  myocardial  infarction  (also  in  subendocardial  form)  with 
manifestation  similar  to  the  post-cardiac  injury  syndrome.  Cardiac  tamponade  may  occur 
relatively  early.  Late  constriction  is  rare  but  not  surprising  because  of  intrapericardial 
organization of exudates and blood .This also can produce loculated effusions. Ibuprofen is the 
agent of choice. Aspirin, up to 650mg every four hours for 2-5 days, corticosteroid treatment is 
used for refractory symptoms but can delay infarction healing.
Neoplastic pericarditis 
It  is  40  times  more  often  caused  by  secondary  than  primary  malignancies,  most 
frequently by lung cancer, breast cancer, malignant melanoma, lymphomas, and leukemias. The 
diagnosis  is  based  on  pericardial  fluid  cytology  and  pericardial/epicardial  biopsy  findings. 
CT/MRI  can  reveal  localization  of  the  primary  tumor  or  the  metastases.  Pericardial  fluid 
cytology is positive in 75-87% and pericardial biopsy in 27-65% of patients with malignant 
pericardial disease. However pericardial biopsies guided by pericardioscopy have a diagnostic 
value  of  93.3  -97%.  Increased  concentrations  of  specific  tumor  markers  (for  example, 
carcinoembryonic antigen (CEA), α-feto protein (AFP), carbohydrate antigens CA 125, CA 72-
4,  CA15-3,  CA 19-9,  CD-30,  and CD-25)  may also suggest  the  diagnosis.  In  60% of the 
patients  with  documented  malignancy,  pericardial  effusion  is  caused  by  non-malignant 
diseases-for example radiation pericarditis or opportunistic infections.
Systemic  antineoplastic  treatment  is  the  baseline  therapy  and  pericardiocentesis  is 
required to relieve symptoms and establish diagnosis. Intra-pericardial instillation of cytostatic/ 
sclerosing agents is also useful in recurrent pericarditis. Recurrences are observed in 40-70% of 
patients with large malignant pericardial effusion. It is treated intrapericardial instillation of 
sclerosing  agents,  cytotoxic  drugs,  immunomodulators,  systemic  antitumour  therapy, 
percutaneous balloon pericardiotomy, radiation therapy or surgical  methods.  Intrapericardial 
administration of cisplatin is effective in 83-93% of cases. It has the following side effects like 
fever  (19%),  chest  pain  (20%),  and  atrial  arrhythmias  (10%).Classic  sclerotherapy  after 
Neoplastic pericarditis in 
Hodgkin’s disease.
A. Pericardioscopy 
findings.
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Epicardium
intrapericardial  instillation  of  tetracycline,  doxycycline,  minocycline,  and  bleomycin  is  an 
effective procedure. The development of constrictive pericarditis secondary to fibrosis remains 
a severe problem in long term survivors. Antineoplastic drugs (5-fluorouracil and aclarubicine) 
or immunomodulators (interferon, interleukin-2, OK-432) have been tested only in very small 
numbers  of  patients.  Radiation  therapy  is  very  effective  (93%)  in  controlling  malignant 
pericardial effusion in patients with radiosensitive tumors such as lymphomas and leukemias. A 
percutaneous  balloon pericardial  window creates  a  pleuropericardial  direct  communication, 
which allows fluid to be drained into the pleural space. Pericardiectomy is rarely indicated, and 
mainly used for treating pericardial constriction or complication or previous procedures
Chylopericardium
Chylopericardium  refers  to  a  communication  between  the  pericardial  sac  and  the 
thoracic  duct  caused  by  congenital  anomalies,  trauma,  mediastinal  lymphangiomas, 
lymphangiomatous  hamartomas,  mediastinal  or  pericardial  lymphangiectasis,  obstruction  or 
anomalies of the thoracic duct, or caused iatrogenically during surgery. The chylous nature of 
the fluid is confirmed by its alkaline reaction, specific gravity between 1010 and 1021, Sudan 
III  stain  for  fat,  and  the  high  concentrations  of  triglycerides  (5-50g/L)  and  protein  (22-
60g/L).Enhanced CT alone or combined with lymphography, is a reliable diagnostic tool for 
identifying not only the location of the thoracic duct but also its lymphatic connection to the 
pericardium. Pericardiocentesis  and diet  are the principal  therapy. After  initial  drainage the 
disorder may be resolved through dietary management with medium chain triglycerides alone. 
If further production of chylous effusion continues, surgical treatment is mandatory. Pericardio-
peritoneal shunting by means of a pericardial window is a reasonable option. When the course 
of the thoracic duct had been precisely identified, ligation and resection of the thoracic duct just  
above the diaphargam has proved to be the most effective treatment.
Idiopathic chronic pericardial effusion:
When a large pericardial effusion persists for more than three months, the prognosis, 
even in asymptomatic patients, is less good. Sagrista-Sauleda etal, have reported that up to 29% 
of such patients may develop unexpected, overt cardiac tamponade. Echocardiography can be 
used to assess the severity of pericardial effusion based on the size of effusions:  (1) small 
(echo-free space in diastole <10mm); (2) moderate (at least ≥ 10mm posteriorly); (3) large 
(≥20mm); or (4) very large (≥20mm with compression of the heart). Colombo etal, consider 
effusions greater than 10mm by M mode echocardiography as large, effusions if they were 
greater than 5mm as small effusion. In the series by Sagrista –Sauleda etal, moderate effusions 
were defined as an echo-free space of anterior plus posterior pericardial spaces of 10-20mmm 
during  diastole, and severs effusions as a sum of echo-free spaces greater than 20mm.
The trigger of tamponade is unknown, but hypovolaemia, paroxysmal tachyarrhythmia, 
and intercurrent acute pericarditis may precipitate tamponade, accordingly, these events should 
be  vigorously  managed.   Anti-inflammatory  drugs  and  corticosteroids  are  unsuccessful. 
Pericardiocentesis  is  indicated  in  patients  with  overt  clinical  tamponade,  in  patients  with 
suspicion  of  purulent  pericarditis,  and  in  patients  with  idiopathic  chronic  large  pericardia 
effusion.
Approach to pericardial effusion:
Cardiac Tamponade:
It  is  usual  in  acute  pyogenic,  tuberculous,  and  malignant  pericarditis.  Acute 
haemopericardium may cause tamponade following cardiac rupture after myocardial infarction, 
in dissection of the aortic root or after cardiac surgery. Metastatic carcinoma, as well as primary 
tumors, may present with tamponade. 
Characteristics of Cardiac Tamponade:
Clinical presentation Raised systemic venous pressure hypotension, pulsus 
paradoxus  ,tachycardia,  dyspnea  or  tachypnea  with 
clear lungs
Precipitating factors Drugs  (cyclosporine,  anticoagulants,  thrombolytics, 
etc),recent  cardiac   surgery,  indwelling 
instrumentation,  blunt  chest  trauma,  malignancies, 
connective  tissue disease, renal failure, septicemia 
ECG Can  be  normal  or  non-specifically  changed  (ST-T 
wave),  electrical  alternans  (QRS,  rarely  T), 
bradycardia  (end  stage),  electromechanical 
dissociation (agonal phase)
Chest x ray Enlarged cardiac silhouette with clear lungs
Mmode/2D 
echocardiogram
Diastolic collapse of the anterior RV free wall , RA 
collapse,  LA and rarely LV collapse,  increased  LV 
diastolic wall thickness - “pseudo hypertrophy”, VCI 
dilatation  (no  collapse  in  inspiration),  “swinging 
heart”
Doppler Tricuspid  flow increases  and mitral  flow decreases 
during inspiration (reverse in expiration) Systolic and 
diastolic  flows  are  reduced  in  systemic  veins  in 
expiration  and  reverse  flow  with  contraction  is 
increased 
M mode colour Doppler Large  respiratory  fluctuations  in  mitral  /tricuspid 
flows  
Cardiac catheterization Confirmation of the diagnosis and quantification of 
the hemodynamic compromise:
RA pressure is raised (preserved systolic X descent 
and absent or diminished diastolic y descent)
Intrapericardial  pressure is  also raised and virtually 
identical  to  RA pressure  (both  pressures  fall  in 
inspiration)
RV mid-diastolic pressure raised and equal to the RA 
and pericardial pressures 
Pulmonary  capillary  diastolic  pressure  is  slightly 
raised and may correspond to the RV pressure 
Pulmonary  capillary  wedge  pressure  is  also  raised 
and nearly equal to intrapericardial and right atrial 
pressure 
LV systolic  and  aortic  pressure  may  be  normal  or 
reduced   
 documenting that pericardial  aspiration is followed 
by hemodynamic improvement 
detection  of  the  coexisting  hemodynamic 
abnormalities  (LV  failure,  constriction, 
pulmonary hypertension)
detection  of  associated  cardiovascular  diseases 
(cardiomyopathy)  
RV/LV angiography Atrial  collapse  and  small  hyperactive  ventricular 
chambers
Coronary angiography Coronary compression in diastole 
Atypical Tamponade:
Low pressure tamponade occurs in the following conditions:
 Hypovolaemia 
 Trauma
 Excessive diuretic 
 Treatment
 Haemodialysis
Impending Cardiac Tamponade:
Some patients with pericardial effusion but without clinical tamponade show findings 
suggesting  raised  intra-pericardial  pressure-namely,  collapse  of  the  right  sided  cardiac 
chambers. These findings indicate the “impending” cardiac tamponade. 
Specifically, right atrial collapse had a low positive predictive value (50%) for clinical 
cardiac  tamponade.  However,  these  patients  consistently  show elevation  of  intrapericardial 
pressure when they undergo catheterization study. Pericardiocentesis 
Pericardiocentesis  is  indicated  for  clinical  tamponade,  suspicion  of  purulent  or 
neoplastic pericarditis, or for symptomatic patients, despite medical treatment for more than 
one week. Pericardiocentesis is indicated if additional diagnostic procedures are available (for 
example,  pericardial  fluid  and  tissue  analyses,  pericardioscopy,  and  epicardial/pericardial 
biopsy) to reveal the etiology of the disease and permit further treatment. Aortic dissection is a 
major contraindication; uncorrected coagulopathy, anticoagulant treatment, thrombocytopenia 
<50000/mm, and small, posterior, and loculated effusions are other relative contraindications 
for performing the procedure. 
Pericardiocentesis may allow the resolution of effusion in a third of patients. When large 
effusion  reappears  after  two  pericardiocentesis,  wide  anterior  Pericardiectomy  has  to  be 
considered. The indications for surgical drainage are tamponade, either unresolved or relapsing 
after pericardiocentesis, and persistent active illness three weeks after hospital admission. Even 
the presence of echocardiographic right chamber collapse (suggesting raised intrapericardial 
pressure) does not warrant by itself pericardial drainage as most of these patients do not evolve 
to overt tamponade. Routine pericardial drainage is not justified in the initial management of 
patients with large pericardial effusion without clinical tamponade, especially if the etiology is 
known.  The  exceptions  would  be  those  patients  with  suspected  purulent  or  tuberculous 
pericarditis
Asbestos induced pericardial effusion and constrictive pericarditis:
Asbestos  produces  progressive  fibrosis  of  the  pericardium that  is  similar  to  diffuse 
pleural thickening and may be fatal. Both conditions may develop after relatively short or light 
exposure. In a study by Davies D etal, three cases have been reported. He reported a man with  
bilateral pleural thickening and plaques developed acute pericarditis and an effusion and he was 
treated  by  pericardiectomy.  Two  men  died  from  constrictive  pericarditis  associated  with 
bilateral pleural effusions and diffusion pleural thickening
Constrictive pericarditis:
Constrictive pericarditis can be defined as a syndrome (or syndromes) resulting from 
compression  of  the  heart  caused  by  rigid,  thickened,  and  frequently  fused  pericardial 
membranes.  
Patterns of Constrictive pericarditis:
Typical forms
Chronic (calcific, rigid shell)
Subacute (non-calcific, elastic)
Effusive-constrictive
Localized
Transient cardiac constriction
Occult constrictive pericarditis
Etiology
Prevalence  of  idiopathic  CCP  has  varied  form  24%  to  61%  in  Indian  studies. 
Tuberculosis  remains  a  common  cause  of  CCP in  developing  countries,  with  a  reported 
incidence  of  38%-83%.  The  etiology  of  CCP in  the  western  world  has  now undergone  a 
significant change, with tuberculosis reported in only 0%-1% of cases in some recent series. 
The leading identifiable causes of CCP are following cardiac surgery and radiation therapy, 
besides  viral  pericarditis.  The  incidence  of  CCP complicating  cardiac  surgery  is  between 
0.025% and 0.15% of patients undergoing open heart surgery. 
Pathogenesis
CCP may result from the progression of an acute pericarditis from a dry stage through an 
effusive,  absorptive,  a  constrictive  phase  sequentially;  or  it  may  result  from a  smoldering 
fibrosis with no previous history of an acute pericarditis. It appears that tubercular pericarditis 
is a hypersensitivity reaction to antigens such as tuberculoproteins. The increased production of 
interferon gamma, tumor necrosis factor-alpha, and interleukin-1 and interleukin 2 in tubercular 
pericardial effusion suggest that the inflammation is orchestrated by T-helper -1 lymphocytes. 
T-lymphocytes  and  activated  macrophages  seem  to  play  an  important  role  in  granuloma 
formation and fibrosis. 
Clinical features:
Constriction is usually generalized but rarely may be localized, owing to constricting 
bands in the left or right atrioventricular grooves or round the entry of the superior or inferior 
vena cava. Most often it is due to tuberculous origin; a few are associated with rheumatoid 
arthritis, collagen vascular disease or uremia, or rarely following cardiac surgery or irradiation. 
The clinical picture includes chronic fatigue and dyspnea, neck vein distension with a brisk 
diastolic collapse (“y”) of the jugular venous pulse, pericardial knock, enlarged liver, ascites, 
peripheral  odema,  and  pleural  effusion.  Arterial  pulsus  paradoxus  is  usually  absent.  Atrial 
fibrillation is present in half of the patients. Constrictive pericarditis should be suspected in all 
patients with findings suggestive of right heart failure or ascites; diagnosis should be based on a 
triad  of:  a  suggestive  clinical  syndrome;  demonstration  of  a  physiology  of 
constriction/restriction; and demonstration of a thickened pericardium. 
Characteristic of constrictive pericarditis:
Clinical presentation Severe  chronic  systemic  venous  congestion 
associated  with  low  cardiac  output,  including 
jugular venous distension, hypertension with a low 
pulse  pressure,  abdominal  distension,  edema,  and 
muscle wasting   
ECG Can  be  normal,  or  reveal  low  QRS  voltage, 
generalized   T  wave  inversion/flattening,  LA 
abnormalities,  atrial  fibrillation,  atrioventricular 
block, intraventricular conduction defects, or rarely 
pseudo infarction pattern  
Chest x ray Pericardial calcifications, pleural effusions
M mode/2D echocardiogram Pericardial thickening and calcifications as well as 
the indirect signs of constriction:
RA and LA enlargement with normal appearance of 
the ventricles, and normal systolic function
Early pathological outward and inward movement 
of the interventricular septum 
Flattering waves at the LV posterior wall
LV diameter is not increasing after the early rapid 
filling phase
VCI and the hepatic veins are dilated with restricted 
respiratory fluctuations  
Doppler Restricted filling of both ventricles with respiratory 
variation >25% over the AV valves 
TOE Measurement of the pericardial thickness
MRI Measurement of the pericardial thickness
Cardiac catheterization “Dip  and  plateau”  or  “square  route”  sign  in  the 
pressure curve of the right and /or left ventricle 
Equalization of pressures in the range of 5mm Hg 
or less 
RV/LV angiography The reduction of RV and LV size and increase of 
RA and LA size 
During  diastole  a  rapid  early filling  with  stop  of 
further enlargement (“dip-plateau”)
Coronary angiography In all patients over 35 years and in patients with a 
history of mediastinal irradiation, regardless of the 
age.  
                                                                   
Mitral flow velocity Doppler Cardiac Catheterisation
  
Pulsed wave Doppler of the pulmonary veins in constrictive pericarditis.
Pulsed wave Doppler of the pulmonary veins of a patient with constrictive pericarditis. Note 
the inspiratory decrease of the S and P waves and the expiratory increase due to interventricular  
dependence.  (Inspiration  is  denoted by the  upward arrow and expiration by  the  downward 
arrow).
Pericardial calcification
  
Calcification  occurred  most  frequently  in  patients  with  idiopathic  constriction  and patients 
longer  duration  of  symptoms.  The  association  of  pericardial  calcification  with  larger 
echocardiographic  atrial  dimension  and  volume  is  a  new  observation.  The  presence  of 
calcification independently predicted perioperative death. 
Cardiac MR:
Pericardial  thickening  of  more  than  3mm  is  usually  taken  as  abnormal;  the  usual 
thickening of the pericardium being 1-2mm. Pericardial thickening on MRI was found to be 
88% sensitive and 100% specific for detecting CCP. Additional findings suggestive of CCP, 
such as dilated inferior vena cava (IVC), enlarged atria, tubular-shaped ventricles, ascites and 
pleural effusion on MRI images. Myocardial tagging has also been suggested as a new method 
of  mitral/tricuspid  annular  movement.  As  normal  ventricles  contract,  there  is  a  slippage 
between the myocardium and pericardium; however, once pericardial adhesions develop, this 
slippage is absent and the tag lines passing through the myocardium and pericardium are not 
deformed during the cardiac cycle. The presence of abnormal diastolic motion of the septum on 
cine MRI may also be a useful finding to diagnose CCP, and to distinguish it from RCM.
CCP with  normal  pericardial  thickness  was  reported  in  18% of  143 patients  in  a  recently 
published series from the Mayo Clinic. These patients most commonly had post-surgical and 
post-radiation CCP.  Their  clinical  characteristics  were  similar  to  patients  with CCP with a 
thickened pericardium,  and  pericardiectomy was  very  effective  in  relieving the  symptoms. 
Microscopy of the excised pericardium was abnormal in all the patients, which included the 
presence of focal fibrosis, focal calcification or inflammation
Comparison of subacute (elastic) and chronic (rigid shell) constrictive pericarditis
Subacute (elastic) Chronic (rigid shell)
Paradoxical pulse usually present, other 
signs  of  interdependence  usually 
prominent
Paradoxical  pulse  usually  minimal  or  absent, 
other signs of interdependence less prominent
Usually an XY waveform (“M” or “W” 
waveform) Y is predominant, X sometimes minimal
Dip-plateau  pattern  less  conspicuous, 
because  early  diastolic  nadir  may  not 
approach zero
Dip-plateau usually conspicuous, because early 
diastolic nadir often reaches zero.
Calcification usually absent Calcification often present
Pericardial  effusion  sometimes  present, 
generalized or  loculated,  constriction is 
by the visceral pericardium
Pericardial  effusion absent.  The two layers  of 
pericardium are fused, and jointly constrict the 
heart.
P waves usually normal P  waves  often  wide,  notched  and  low  in amplitude
Atrial fibrillation or flutter rare Atrial fibrillation or flutter common
Effusive –constrictive pericarditis:
Effusive- constrictive pericarditis is a clinical –hemodynamic syndrome in which there 
is  constriction of  the  heart  by  the  visceral  pericardium in the  presence of  effusion in  free 
pericardial  space.  This  type  of  constrictive  pericarditis  was  first  characterized  from  the 
hemodynamic  point  of  view  by  Hancock  in  his  report  on  13  patients  submitted  to 
Pericardiectomy.  The  hallmark  of  effusive-constrictive  pericarditis  is  the  demonstration  of 
persistently raised right atrial and end diastolic ventricular pressure after the intrapericardial 
pressure is reduced to normal levels by removal of pericardial fluid. The etiologic spectrum 
includes  idiopathic,  following  cardiac  surgery,  neoplasia  and  tuberculosis.  Patients  with 
effusive-constrictive  pericarditis  usually  show  a  sub  acute  evolving  clinical  course  with 
inflammatory symptoms and signs.  Most cases of  effusive –constrictive pericarditis  require 
Pericardiectomy.  Effusive-constrictive  pericarditis  may  be  transient  and  may  resolve 
spontaneously, especially in idiopathic cases.
Transient cardiac constriction:
Reported on 16 patients from a series of 177 with effusive acute idiopathic pericarditis 
in  which  features  of  constriction  were  detected  in  the  phase  of  resolution  of  pericarditis. 
Clinical  (pericardial  knock  on  auscultation,  “y”  collapse  in  the  jugular  venous  pulse)  and 
echocardiographic  (early  diastolic  septal  notch)  features  of  constriction  were  frequently 
present,  and  two  patients  had  overt  signs  of  venous  congestion.  In  five  patients,  cardiac 
catheterization was carried out and disclosed features of constrictive pericarditis in all, either in 
the baseline state or after fluid challenge. After a mean period of 2.7 months the clinical and 
hemodynamic features of  constriction spontaneously subsided.  Although most patients  with 
acute pericarditis proceed directly to complete resolution, in some recovery may be preceded 
by transient constriction; in some patients it may develop in to sub acute effusive-constrictive 
pericarditis, sometimes it may be followed by classical contractive pericarditis, or the condition 
may  directly  progress  to  sub  acute  or  chronic  constriction.  Transient  constriction  would 
represent  an intermediate  link between uncomplicated recovery  and the  severe,  irreversible 
types of constriction. Such an event occurred in 15% of patients with tubercular pericarditis in 
one report  from South  Korea.  The resolution  occurred within  2 months  in  the  majority  of 
patients. Perhaps transient CCP could occur even more often with purulent pericarditis.
Occult constrictive pericarditis:
The term occult constrictive pericarditis was introduced in 1977 by Bush and associates. 
They  reported  on  19  patients,  most  with  idiopathic  pericarditis,  in  whom  physical  and 
hemodynamic features of constriction were not apparent in their baseline state, but which were 
brought about by the rapid infusion of saline.
Patterns of Constrictive pericarditis in various pericardial diseases:
 Patients  with  acute  pericardial  disease,  severe  sub  acute  constriction  requiring 
pericardiectomy developed in 56% (9/16) and 35% (6/17) of patients  with tuberculous and 
purulent pericarditis,  respectively, and in 17%(2/12) of patients with neoplastic pericarditis. 
Only  2  of  177  patients  with  acute  idiopathic  pericarditis  developed  effusive-constrictive 
pericarditis requiring Pericardiectomy. Constriction was subacute, developing within the first 
six months of follow up. A patient with subacute constriction after acute pericardial disease is 
much more likely to have a specific pericarditis than an idiopathic pericarditis. 
Transient  constriction  is  much  more  frequent  in  patients  with  idiopathic  pericarditis 
(with  a  prevalence  of  20%  when  specifically  sought)  than  in  tuberculous  or  purulent 
pericarditis.
Pericardiectomy 
Pericardiectomy  is  the  only  therapeutic  approach  that  may  remove  permanent 
constriction, by aiming to resect the diseased pericardium as far as possible. The indications for 
surgery should be based upon clinical symptoms, echocardiography   findings, CT/MRI, and 
heart catheterization. There are two standard approaches: (1) antero-lateral thoracotomy (fifth 
intercostal space); and (2) median sternotomy (faster access to the aorta and right atrium if 
extracorporeal circulation becomes necessary. If severe calcified adhesions between the peri-
and epicardium are present, or if the epicardium is generally affected (“outer porcelain heart”),  
surgery  carries  a  high  risk  of  either  incomplete  success  or  sever  myocardial  damage.  An 
alternative approach in such cases may be “laser shaving” using an Excimer laser. Areas of 
strong calcification or dense scaring may be left as islands, separated from the other areas, to 
avoid bleeding. Major complications include acute perioperative cardiac insufficiency (regional 
bulging or  complete dilatation of  one or  both ventricles)  and ventricular  wall  rupture.  The 
surgical mortality of pericardiectomy continues to be high, and has been generally reported to 
be 6%-12%. A subgroup of patients with calcific CCP had a mortality of 19% in a recent series. 
The negative predictors of survival after pericardiectomy include NYHA class IV, low-voltage 
ECG complex, markedly increased atrial pressure, associated organ failure, and post-radiation 
CCP. The occurrence of low cardiac output following CCP is often a reflection of the chronicity 
of  CCP and  associated  myocardial  atrophy.  Acute  cardiac  dilatation  and  failure  following 
pericardiectomy  may  occur  unpredictably.  Preoperative  inotropes  for  48  hours,  and 
preoperative digitalization are often used to reduce the chances of postoperative heart failure 
but  their  effectiveness  is  not  clear.  Multiple  incisions  into  the  fibrous  epicardium  while 
protecting the myocardium and coronary arteries are useful in relieving the constriction (waffle 
procedure). In patients with extensive calcific plaques, where large plaques do not permit the 
development of cleavage planes, wedge incisions that reach up to the epicardium help release 
constriction. More recently, ultrasonic decalcification has been used in tough calcific lesions. 
Complete normalization of cardiac hemodynamic after the procedure has been reported in only 
60% of patients. Postoperative low cardiac output should be treated by fluid substitution and 
catecholamine,  high doses  of  digitalis,  and,  in  the  most  severe  cases,  intra  –aortic  balloon 
pump.
Relapsing pericarditis:
The term relapsing pericarditis includes two clinical types, the incessant type and the 
intermittent type of recurrent pericarditis. The term incessant applies to those patients in which 
discontinuation or attempts to wean from anti-inflammatory treatment nearly always ensure a 
relapse in a period of less than six weeks. This situation can be seen after discontinuation of the 
usual anti-inflammatory drugs (aspirin,  indomethacin,  or ibuprofen).The term “intermittent” 
refers  to  those  patients  with  symptom-free  intervals  conventionally  longer  than  six  weeks 
without treatment. Their frequency in clinical series is between 8-80% with the average of 24% 
The most typical from or relapsing pericarditis occurs after a first episode of idiopathic 
benign pericarditis,  presumably  of  viral  origin.  The  viruses  most  frequently  implicated are 
Enterovirus,  mainly  Coxsackie’s  B.  Autoimmune response  can  certainly  play  a  role  in  the 
pathogenesis of recurrent idiopathic or post viral pericarditis. Relapsing pericarditis can also 
occur in the post-myocardial and post-pericardial injury syndromes. Relapses after open heart 
surgery seem to more frequent in children and adolescents, especially after atrial open heart  
surgery seem to be more frequent in children and adolescents,  especially  after atrial  septal 
defect closure. Genetic factors may play a role in the development of a relapse as well. An  
immunopathologic mechanism seems to be evident in the relapsing pericarditis of vasculitis or 
connective tissue disease, especially disseminated lupus erythematosus. Neoplastic pericarditis 
can shown an oscillating clinical course, and, occasionally, apparently self limited pericarditis 
with subsequent reappearance of pericardial manifestations. 
The pattern of relapsing pericarditis is quite characteristic in that the index attack usually 
is  the  most  severe,  while  subsequent  episodes  are  milder.  So in  some patients  the  clinical 
manifestations in relapses are limited to “pericardial” pain only. In  the historical series by 
Fowler and Harbin that included 31 patients with recurrent acute pericarditis, all patients had 
pericardial  friction  rub   and  evidence  of  pericardial  effusion  or  characteristic 
electrocardiographic  changes  in  the  index attack,  while  these  manifestations   were  entirely 
absent in subsequent relapses in seven patients. In these patients the evidence of pericarditis 
(apart  from pericardial  pain)  was provided by an increased erythrocyte  sedimentation rate, 
while blood cell counts, or fever. In the series by Fowler and Harbin tamponade was present in  
the initial attack in three patients, but in none of the recurrences. The drug of first choice is 
aspirin, 250-500mg orally every 4-6hours. Paracetamol (acetaminophen), 500-750mg every 4-
6hours, can be successfully used in patients with mild to moderate symptoms. In patients with 
severe symptoms, the most effective drugs are indomethacin (25-50 mg every 6-8hours) and 
ibuprofen (800mg every 6-8hours). Corticosteroids are very effective drugs that quickly control 
pain and pericardial effusion. Corticosteroid administration may favour the relapses whenever 
the dose is diminished, leading to recurrent pericarditis. Prednisone can be quickly reduced 
from  initial  high  doses  (1mg/kg/day)  to  the  threshold  level  below  which  symptoms  will 
probably recur (usually 5-15mg/day). From this point on, the doses of prednisone should be 
reduced very slowly in decrements of as little as 1mg.Doses can usually be reduced at intervals 
of between one week and two months, and can be given on alternate day. Pericardiectomy 
should be considered to be the last resort in patients with severe relapsing pericarditis in whom 
an adequate drug treatment has failed.  
AIM
To  find  out  the  etio-pathological  and  clinical  profile  of  patients  with  Chronic 
Pericarditis.
OBJECTIVES
 To analyze the etiological profile patients with chronic pericarditis.
 To describe the pathological findings in various chronic pericarditis.
 To elicit the clinical profile of chronic pericarditis. 
MATERIAL AND METHODS
Study Design:
This  study is  a  descriptive  study.  This  study was conducted  to  describe  the  various 
etiologies in patients with chronic pericarditis.
Total no. of patients:  
There were totally 50 patients were included in this study.
Place of study:
This  study  was  conducted  in  Government  Rajaji  Hospital,  Madurai.  50  consecutive 
patients who were attending Cardiology out patients department fulfilling the inclusion criteria 
were included in this study.
Study Period:
This study was conducted from August 2003- August 2005.
Inclusion Criteria:
 Patients  with clinical features of chronic pericarditis which lasted for more than three 
months were included.
 All patients with the diagnosis chronic pericardial effusion; Chronic Cardiac Tamponade; 
Chronic Constrictive pericarditis were included in this study. 
Exclusion Criteria:
 All patients with clinical features of pericarditis which lasted for less than three months 
were excluded.
Consent:
 We got informed consent in all our study population. 
All patients were underwent a proper systematic clinical examination as mentioned in 
the  Proforma  immediately  after  the  enrollment.  Complete  Hemogram  (Hemoglobin;  Total 
WBC  Count;  Differential  Count;  ESR)  Biochemical  investigations  (Blood  urea;  Serum 
creatinine) were done in all patients. Chest X-ray was taken in both PA & Lateral views in all 
patients. 
Surface ECG:
Surface ECG was taken in  all  patients.  ECG was analyzed for  the  presence of  low 
voltage complexes, atrial enlargement, arrhythmias. Low voltage complex was defined if QRS 
voltage in leads I, II, III each less than 0.5 mV, or V1 to V6 each less than 1.0 mV.  
Echocardiographic examination:
In  all  patients  2D  & M Mode  &  Doppler  examination  was  done.  In  M Mode  we 
analyzed  the  septal  motion,  septal  notch;  septal  bounce;  pericardial  fluid  quantification; 
pericardial  thickness  & posterior  wall  movement.  The  severity  of  pericardial  effusion  was 
classified based on the size of effusions: (1) small (echo-free space in diastole <10mm); (2) 
moderate (at least ≥ 10mm posteriorly); (3) large (≥20mm); or (4) very large (≥20mm with 
compression of the heart.  In 2D Echo we specifically we looked for the presence of early  
diastolic Right atrial collapse and the presence of collapse of the free wall of Right ventricle. 
The Doppler examination was done to find out the flow variation during the both phases of  
respiration. We analyzed the respiratory flow variation in mitral valve; Tricuspid valve.  We 
also analyzed the respiratory flow variation in hepatic vein and Pulmonary vein. 
Transesophageal Echocardiographic examination was done in all patients. This modality 
was used mainly to assess the respiratory flow variation in pulmonary vein and also for the  
accurate measurement of pericardial thickness.  Pericardial  biopsy  was  taken  in  27 
patients.  In  all  27  patients  the  biopsies  were  analyzed  by  histopathological  examination. 
Bacterial;  Tuberculous  &  fungal  cultures  were  taken  in  all  27  patients.  DNA PCR  for 
mycobacterium Tuberculosis was done in 5 patients.
Polymerase chain reaction to detect Mycobacterium tuberculosis in 
Pericardial tissue (DNA-PCR):
Mycobacterium  tuberculosis infection  can  be  identified  by  detecting 
M.tuberculosis  specific  DNA sequence  in  tissue  samples.  IS6110,  an  insertion  sequence 
(transposon)  specific  for  M.tuberculosis  and  M.bovis  and devR gene  responsible  for  the 
synthesis of DevR, (a protein involved in the signal transduction system of  Mycobacterium 
tuberculosis;  which  also  found  in  Mycobacterium  bovis) are  the  widely  used  genome 
sequences.
Methods:
Genomic  DNA  was  extracted  from  the  pericardial  tissue  using  the 
Phenol/Chloroform/Isoamylalcohol  method  and  quantitated.  PCR  was  performed  for  the 
IS6110 insertion element and devR gene in a final volume of15 uL with 100 ng of DNA as 
template. The PCR product was electrophoresed in a 1.5 % agarose gel for 30 minutes at 100 
volts. The Agarose gel was then visualized under UV light and documented using a Kodak 
digital image analysis system.
Table – 1: Baseline Characteristics
Total no. of patients 50
Male 25 (50%)
Age in years (mean ± SD) 34 ± 16
Mean duration of symptoms (in months) 4.2 ± 4.3
Clinical Profile
Dyspnea class II to IV 44 (88%)
Facial puffiness 30 (60%)
Pedal edema 30 (60%)
Chest pain 25 (50%)
Fever 22 (44%)
Hypothyroidism 6 (12%)
Chronic renal failure 4 (8%)
Previous H/o tuberculosis 4 (8%)
H/o rheumatic fever 1 (2%)
Acute myocardial infarction 1 (2%)
H/o irradiation Nil
Mean pulse rate (per min) 93 ± 16
Elevated jugular venous pressure 33 (66%)
Pulses paradoxus 13 (26%)
Pericardial knock 9 (18%)
Table  1  describes  the  baseline  characteristics  of  the  study  population.  Totally  fifty 
patients were included in this study. Out of them 25 (50%) patients were male. The mean age of 
our study population was 34 ± 16.3.  Dyspnea was the predominant symptom in our study 
population. 44 (88%) patients had Dyspnea. Facial puffiness was present in 30 (60%) patients. 
Only 4 patients (8%) had previous history of Tuberculosis. 4 patients (8%) had evidence of 
chronic renal failure and 6  (12%)  patients had evidence of hypothyroidism. 13 patients (26%) 
had pulsus paradoxus and 9 patients had pericardial knock.
Table – 2: Patterns of Chronic Pericarditis
Pericardial Disease Total No. of Patients
Pericardial Effusion  (PE) Small 2 (4%)
Moderate 11(22%)
Large 14 (28%)
Constrictive Pericarditis  (CCP) 12(24%)
Cardiac Tamponade (CT) 11(22%)
Table  2  describes  the  profile  of  our  study  population.  12  (24%)  had  constrictive 
pericarditis and 11 (22%) had Cardiac Tamponade. 27 patients (54%) had pericardial effusion. 
Out  of  27patients  14(52%)  patients  had  large  pericardial  effusion;  11(41%)  patients  had 
moderate pericardial effusion and 2(7%) patients had small pericardial effusion.
Table – 3: Clinical Profile
Pericardial 
Effusion  (PE)
Constrictive 
Pericarditis  (CCP)
Cardiac 
Tamponade (CT)
Age in Years 
(Mean ± SD)
39 ± 16 20 ± 8 34 ±12
Male (%) 9 (33%) 9 (75%) 7 (64%)
Duration of 
symptoms 
(months)
4.8 ± 5.6 4.1 ± 2.6 3.0 ± 0.2
Previous 
evidence of 
tuberculosis
1 (4%) 2 (16%) 1 (9%)
Dyspnea 25 (92%) 11 (91%) 8 (72%)
Facial Puffiness 16 (59%) 8 (66%) 6 (54%)
Pedal edema 16 (59%) 8 (66%) 6 (54%)
Chest pain 13 (48%) 6 (50%) 6 (54%)
Fever 7 (26%) 11 (91%) 4 (36%)
No.of Patients 
with Pulsus 
Paradoxus 
4 (15%) Nil 9 (82%)
Mean  Jugular 
Venous 
Pressure (cm)
6.9 ±2.6 7.5 ±2.2 9.8 ± 1.3
No.of  Patients 
with Pericardial 
Knock
Nil 9 (75%) Nil
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Fig: 1 Age distribution in the three patterns of chronic pericarditis
Fig 2 -4 the sex distribution in the three forms of chronic pericarditis.
SEX DISTRIBUTION IN PERICARDIALEFFUSION
33%
67%
Male
 Female
SEX DISTRIBUTION IN CCP
75%
25%
Male
 Female
SEX DISTRIBUTION IN CARDIACTAMPONADE
64%
36%
Male
 Female
Table 3 showed the clinical profile of our patients. We divide our study population in to 
three  groups’  namely  pericardial  effusion;  chronic  constrictive  pericarditis;  Cardiac 
Tamponade. The mean age of patients in three groups was 39, 20, and 34 respectively (Fig 1).  
Patients  in  Constrictive  pericarditis  group  were  younger  age  group  than  the  others.  The 
predominant study population in constrictive pericarditis& cardiac Tamponade were male (Fig 
2  & 3).  In  pericardial  effusion  group  predominantly  they  were  female  (Fig  4).  The  mean 
duration of clinical presentation prior to the study was 4.8; 4.1; 3 months respectively. 16% of 
patients in the constrictive pericarditis group had previous evidence of Tuberculosis. 9 Patients 
(82%)  in  cardiac  tamponade  and  4(15%)  in  severe  pericardial  effusion  group  had  pulsus 
paradoxus.  The  mean JVP was  6.9;  7.5;  9.8  respectively.  9  Patients  (75%)  in  constrictive 
pericarditis group had pericardial knock. 
Table – 4: Etiological Profile
Diseases PE CT CCP
Tuberculosis 1(4%) 2(18%) 5(42%)
Rheumatic fever 1(4%) NIL NIL
Irradiation NIL NIL NIL
Myocardial infarction 1(4%) NIL NIL
Chronic renal failure 4(15%) NIL NIL
Hypothyroidism 6(22%) NIL NIL
Idiopathic 14(51%) 9(82%) 7(58%)
(PE = Pericardial effusion; CT = Cardiac Tamponade; CCP = constrictive pericarditis)
Table  4  showed  the  etiological  profile  of  study  population  (Fig  5).  Most  common 
etiology in all the three groups was idiopathic. In CCP 7 patients (58%) belonged idiopathic 
cause and in 5 patients (42%) it was due to tuberculous infection (Fig: 6). In patients with 
cardiac Tamponade in 9 patients (82%) it was due to idiopathic cause and the rest of the 2 
patients (18%) it was due to   tuberculous infection (Fig 7). In patients with pericardial effusion 
14 patients (51%) were idiopathic and 6 patients (22%) were hypothyroid and 4 patients (15%) 
were  in  chronic  renal  failure.   The  rest  of  3  patients  belonged  to  Myocardial  Infarction; 
Rheumatic fever and tuberculous etiology. (Fig 8)
ETIOLOGICAL PROFILE CHRONIC PERICARDITIS
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Fig: 5 the Etiological profile of chronic pericarditis
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Fig: 6 the Etiological profile of constrictive pericarditis
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Fig: 7   the Etiological profile of cardiac Tamponade.
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Fig: 8 The Etiological profile of chronic pericardial effusion
Fig: 9 Chest X-ray lateral view in a patient with CCP showing pericardial calcification
Fig:  10 CT scan showing pericardial calcification in a patient with CCP.
Table 5: Baseline Investigations
PE CCP CT
ESR (mm/hour) 26 ± 21.1 35.6 ± 18 41.6 ± 24.6
CTR (%) in chest X-ray 60 ± 7.4 54.4 ± 3.3 62.3 ± 3.37
Pericardial calcification in X -ray Nil 3(25%) Nil
No. of patients  with  Low voltage 
complexes in  ECG
15 (55%) 6(50%) 9 (82%)
(PE = Pericardial effusion; CT = Cardiac Tamponade; CCP = constrictive pericarditis; CTR = 
Cardiothoracic ratio.)
Table 5 showed the comparison of baseline investigations of our study population. ESR 
was   high in patients with cardiac Tamponade. The mean CTR was also high in patients with 
cardiac Tamponade. 3 patients (25%) showed evidence of pericardial calcification (Fig 9&10). 
9 Patients (82%) had low voltage complex in ECG in patients with cardiac Tamponade.
Fig:  11 Apical 4 chamber view showing diastolic Right Atrial Collapse in a patient with cardiac 
Tamponade.
Fig 12 Apical 4 chamber view showing large pericardial effusion
.
Fig 13.    Parasternal long axis view showing dilated left atrium with thickened pericardium
Fig 14. Parasternal short axis view showing thickened pericardium with mild pericardial 
effusion.
Fig: 15  Respiratory flow velocity variation in mitral valve in a patient with CCP.
Fig: 16  Respiratory flow velocity variation in pulmonary venous flow in a patient with CCP.
Fig: 17 Respiratory flow velocity variation in hepatic venous flow showing prominent 
diastolic flow reversal in a patient with CCP.
Table 6: ECHO characteristics of chronic Pericarditis
Variables PE CCP CT
Right Atrial Collapse NIL Nil 11
Right Ventricular Collapse NIL Nil 11
Septal Bounce NIL 12 Nil
Flat Posterior Wall NIL 12 Nil
Pericardial Thickness (mm) 2.29 ± 0.4 4.4 ± 0.5 2.45 ± 0.5
Pericardial Effusion  (mm) 18.26 ± 5 7.6 ± 2.9 25.4 ± 4.9
MV  flow  velocity  respiratory  variation 
(Mean %)
9.2 ± 2.3 28.3 ± 2.4 24.5 ± 3.6
Total  no.  of  patients  with  prominent 
diastolic  flow  reversal  in  hepatic  vein 
during Expiration.
15 (55%) 11 (91%) 11 (100%)
(PE = Pericardial effusion; CT = Cardiac Tamponade; CCP = constrictive pericarditis)
Table 6 showed Echocardiographic features of patients in chronic pericarditis (Fig 11-
17).  The mean pericardial thicknesses in all the three groups were 2.29; 4.4 and 2.45mm. The 
mean pericardial thickness was high in patient s with constrictive pericarditis group. The mean 
MV flow velocity respiratory variation was high in patients with constrictive pericarditis.
Fig:  18  per operative findings in a patient with CCP
Table7: Peroperative Findings
PE CCP CT
Mean amount of fluid (ml) 466 ± 115 283 ± 135 650 ± 92
No. of pts. with Hemorrhagic fluid 1 (33%) 1 (17%) 6 (54%)
Mean pericardial thickness (mm) - 4.4 ± 0.5 2.4 ± 0.5
(PE = Pericardial effusion; CT = Cardiac Tamponade; CCP = constrictive pericarditis)
Table 7 showed peroperative findings in our  study population.  The mean amount of 
pericardial fluid was high in patients with cardiac Tamponade. The mean amount of pericardial 
fluid  in  patients  with  cardiac  tamponade  was  650  ±  92ml.  6  patients  (54%)  in  cardiac 
tamponade group had hemorrhagic pericardial effusion. The mean pericardial thickness was 
high in patients with constrictive pericarditis. It was 4.4 ± 0.5mm in patients with constrictive 
pericarditis and 2.4 ± 0.5mm in patients with cardiac tamponade (Fig 18).
Table 8: DNA PCR for Mycobacterium Tuberculosis
No. of patients Positive
Constrictive Pericarditis  (CCP) 5 4
 
DNA PCR   for Mycobacterium Tuberculosis was done in 5 patients in the constrictive 
pericarditis group. Out of them 4 patients (80%) were found positive for tuberculous infection 
(Fig 19-20).
Fig 19: Electrophorogram of IS6110 specific PCR product using DNA from 
different pericardial samples with M.tb DNA as positive control
541 bp IS6110
specific amplicon
from M.tb DNA
IS6110 specific PCR 
product from test sample
1                      2                    3                   4
Lanes:
1- M.tb DNA
2- Selvam pericardial effusion blood
3- Selvam pericardial tissue
4- No template control
Fig 20: Electrophorogram of DevR specific PCR product using DNA from
different samples of a single pericarditis patient
513 bp DevR
specific amplicon
Lanes:
1- Pericardial effusion blood
2- Pericardial tissue
3- No template control
1                              2                             3
Fig: 21 histopathological examination of pericardium in a patient with CCP showing Caseating 
granuloma.
Fig: 22 histopathological examination of pericardium in a patient with CCP showing granuloma 
with Langhans giant cell
Table 9: Histopathological Examination
Biopsy PE CP CT
NSPI 3 (100%) 7 (58%) 9 (82%)
Caseating Granuloma  Nil 5 (42%) 2 (18%)
(NSPI = Non Specific Inflammation)
Pericardial biopsy was taken in 3 patients in the large pericardial effusion group and all 
of them showed non specific inflammation. In constrictive pericarditis group 5 patients (42%) 
showed the presence of granulomatous inflammation suggestive of tuberculous infection and 
the rest (58%) showed nonspecific inflammation .In patients with cardiac tamponade only 2 
(18%)  were  positive  for  tuberculous  infection  and  the  rest  (82%)  showed  nonspecific 
inflammation (Fig : 21& 22)  
Table 10: Treatment
PE CP CT
Window Pericardiectomy 3 (11%) Nil 11 (100%)
Treatment with ATT 3 (11%) 12 (100%) 11 (100%)
DISCUSSION
We analyzed totally fifty consecutive patients with chronic pericarditis. The principle 
aim of our study was to find the etiological profile in patients with chronic pericarditis. The 
study population were divided in to three major groups namely pericardial effusion; chronic 
constrictive  pericarditis;  cardiac  Tamponade.  12  (24%) had constrictive  pericarditis  and 11 
(22%) had Cardiac Tamponade and 27 patients (64%) had chronic pericardial effusion. Out of 
27patients with chronic pericardial effusion 14(52%) patients had large pericardial effusion; 
11(41%) patients had moderate pericardial effusion and 2(7%) patients had small pericardial 
effusion.
 In  our  study population  50% were male.   It  was  consistent  with study by  Sagrista-
Sauleda J etal. He analyzed 322 patients with severe pericardial effusion. He found that 166 
patients were (52%) men.  The mean age of our study population was 34 ± 16.3. Our study 
population belonged to younger age group. In the study by Sagrista-Sauleda J etal the mean age 
of his study population was 56 +/- 17 years. His study population was predominantly in the 
elderly population. The mean ages of patients in three groups were 39, 20, and 34 respectively. 
The patients in constrictive pericarditis group were younger than the other two groups.
 Dyspnea was the common presentation in all three groups in our study. In our study 
population only 4 patients  (8%) had previous history of  Tuberculosis.  Clinical  evidence of 
chronic  renal  failure  was  found in  4  patients  (8%)  and  6  (12%)  patients  had  evidence  of 
hypothyroidism. 
The mean duration of clinical presentation prior to the study in all three groups was 4.8; 
4.1; 3 months respectively. In the study by Chen KY, et al, the mean duration between the onset 
of symptoms and diagnosis of chronic pericardial effusion  was longer in patients with shaggy-
type effusion (39.6+/-8.7 vs. 21.0 +/-13.9 days, p<0.05).
In our  study population pulsus  paradoxus was found in 9 Patients  (82%) in cardiac 
tamponade and 4 patients (15%) in severe pericardial effusion. In contrast, the study by Levine 
etal in patients with severe pericardial effusion with tamponade showed pulsus paradoxus in 
only 36% of patients. The mean Jugular Venous Pressure was 6.9; 7.5; 9.8 cm in the three  
groups respectively. In our study all patients with cardiac tamponade showed elevated Jugular 
Venous Pressure. In contrast, the study by Levine etal in patients with tamponade elevation of 
the jugular venous pressure was found in only 74%. In our study population 9 Patients (75%) in 
constrictive  pericarditis  group  had  pericardial  knock.
In  our  study population  9  Patients  (82%)  with  cardiac  Tamponade  had low voltage 
complex in ECG. In contrast,  in study by  Casale etal  using Standard ECG criteria for low 
voltage (leads I, II, III each less than 0.5 mV, or V1 to V6 each less than 1.0 mV) , the low 
voltage complexes was found  in 12% of patients with pericardial effusion with tamponade.
A thickened pericardium can be apparent in a simple chest x ray in case with pericardial 
calcification  or  in  computed  tomography  or  magnetic  resonance  imaging.   In  our  study 
population 3 patients (25%) showed evidence of pericardial calcification. This is consistent 
with other recent report. 27% incidence of pericardial calcification was reported in Being series 
and 5% incidence was reported by Cameron and colleagues in a series of 106 patients most of 
whom had idiopathic or post irradiation constrictive pericarditis. 53% incidence was reported in 
a more recent European cohort, in which idiopathic disease accounted for 50% of cases. An 
early report from the United States calcification was observed in approximately 50% of cases 
of constrictive pericarditis. A recent German study documented calcification in 55% of cases.
The  mean  pericardial  thicknesses  in  the  three  groups  were  2.29;  4.4  and  2.45mm 
respectively in our study. The mean MV flow velocity respiratory variation was high in patients 
with  constrictive  pericarditis.  Amuthan  v  etal  in  his  study  of  16  patients  with  chronic 
constrictive  pericarditis  found,  Doppler  diagnosis  of  constrictive  pericarditis  was  correctly 
made in 90% of patients. He used Doppler flow patterns of respiratory variation in ventricular 
filling (Mitral and Tricuspid forward flow) and central venous flow velocities (hepatic vein 
diastolic flow reversal) of more than 25% for the diagnosis of chronic constrictive pericarditis.  
Right  atrial  collapse  and  right  ventricular  collapse  was  found  in  all  patients  with  cardiac 
tamponade.  In  the  study  by  Levine  and  colleagues,  50  consecutive  patients  with  severe 
pericardial effusion with tamponade were analyzed. Right atrial collapse was present in 92%, 
and right ventricular collapse in 57% of patients. In the study by Merce etal in 110 patients with 
moderate or severe pericardial effusion,   only 34% of patients showed collapse of one or more 
cardiac chambers.
The mean amount of pericardial fluid in patients with cardiac tamponade was 650 ± 
92ml. 6 patients (54%) in cardiac tamponade group had hemorrhagic pericardial effusion. The 
mean pericardial thickness was high in patients with constrictive pericarditis. 
DNA PCR   for Mycobacterium Tuberculosis was done in 5 patients in the constrictive 
pericarditis group. Out of them 4 patients (80%) were found positive for tuberculous infection.
We found the most common etiology for all the three groups of chronic pericarditis was 
idiopathic. This was consistent with preexisting studies. In Patients with chronic constrictive 
pericarditis 7 patients (58%) belonged to idiopathic cause and in 5 patients (42%) it was due to 
tuberculous infection.  Cacoub P et al studied the etiology profile in patients with constrictive 
pericarditis  in  13  patients.  He  found  neoplasia  in  4  patients,  pericarditis  as  a  sequelae  of 
radiotherapy in 2 patients, as a result of injuries in 2 patients. Pericarditis  due to mediastinal 
and retroperitoneal fibrosis in 2 patients ,  post myocardial infarction pericarditis  in 1 patient,  
purulent pericarditis in 1patient and bacteriologically proven tuberculosis in 1 patient.  
  
Tuberculous infection was found in patients with cardiac Tamponade only in 2 (18%) 
patients. 
In  patients  with  chronic  pericardial  effusion specific  etiology was found only  in  13 
(49%)  patients.  Out  of  them 6  patients  (22%)  were  found  to  have  hypothyroidism and  4 
patients (15%) had pericardial effusion due to chronic renal failure. 1 patient (4%) had post 
Myocardial Infarction pericarditis; 1patient (4%)  had pericardial effusion as a result of chronic 
Rheumatic  carditis  and 1patient  (4%)  had tuberculous  etiology.  The rest  of  the  14 (51%) 
patients were idiopathic. In a study by Olivier Nugue etal, One hundred forty-one consecutive 
patients with  unexplained  pericardial  effusion  underwent  pericardioscopy with  a  rigid 
mediastinoscope. For each patient, the etiologic data obtained by pericardioscopy (visualization 
of pericardium, guided biopsies, subxiphoid window biopsy, and fluid analysis) were compared 
with the results that would have been obtained  with only conventional surgical drainage and 
biopsy (subxiphoid window biopsy and fluid analysis). After complete workup, a specific cause 
was  found  in  69  cases  (48.6%);  the  other  73  cases were  considered  idiopathic  effusions 
(51.4%). Colombo at al in his study he found that the etiologies of large pericardial effusion 
were: neoplastic (36%), idiopathic (32%), uremic (20%), post myocardial infarction (8%), and 
acute rheumatic fever (4%). Sagrista-Sauleda J etal in his study found that the most frequent 
etiologic diagnoses were idiopathic pericarditis (n = 66 [20%]), iatrogenic effusions (n = 50 
[16%]), cancer (n = 43 [13%]), and chronic idiopathic pericardial effusion (n = 29 [9%]).   
 
CONCLUSION
 In patients with chronic pericardial effusion specific etiology was found in 13 patients 
(49%). Out of them 6 patients (22%) had hypothyroidism; 4 patients (15%) had chronic 
renal failure; 1 patient (4%) had post Myocardial Infarction pericarditis; 1patient (4%) had 
chronic Rheumatic carditis and 1patient (4%) had tuberculous etiology. 
 In CCP 5 patients (42%) had tuberculous etiology and the rest (58%) were idiopathic.
 In cardiac Tamponade 2 patients (18%) were found to have tuberculous infection and the 
remaining 9 patients (82%) were idiopathic.
 The most common cause in all the three groups of chronic pericarditis was idiopathic.
SUMMARY
We included fifty consecutive patients with features of chronic pericarditis in this study. 
The study was conducted in our department in Government Rajaji Hospital, Madurai. In our 
study 12 (24%) patients had chronic constrictive pericarditis (CCP) and 11 (22%) had Cardiac 
Tamponade (CT). 27 patients (64%) had pericardial effusion (PE). Out of 27patients 14(52%) 
patients had large pericardial effusion; 11(41%) patients had moderate pericardial effusion and 
2(7%) patients had small pericardial effusion. Patients in Constrictive pericarditis group were 
younger age group than the others. The study population in constrictive pericarditis& cardiac 
Tamponade were predominantly male. In pericardial effusion group predominantly they were 
female. The mean duration of clinical presentation prior to the study was 4.8; 4.1; 3 months 
respectively. 16% of patients in the constrictive pericarditis group had previous evidence of 
Tuberculosis. 9 Patients (82%) in cardiac tamponade and 4(15%) in severe pericardial effusion 
group had pulsus paradoxus. The mean JVP was 6.9; 7.5; 9.8 in the three groups respectively. 9 
Patients (75%) in constrictive pericarditis group had pericardial knock. 
Most common etiology in all the three groups was idiopathic. In CCP 5 patients (42%) 
had  tuberculous  pericarditis  and  the  rest  (58%)  were  idiopathic.  In  patients  with  cardiac 
Tamponade 2 (18%) patients had tuberculous etiology and the rest (82%) were idiopathic. In 
patients with pericardial effusion 14 patients (51%) were idiopathic and 6 patients (22%) were 
hypothyroid  and  4(15%)    patients  were  in  chronic  renal  failure.   The  rest  of  3  patients 
belonged  to  Myocardial  Infarction;  Rheumatic  fever  and  tuberculous  etiology.  The  mean 
pericardial thicknesses in all the three groups were 2.29; 4.4 and 2.45mm. The mean MV flow 
velocity respiratory variation was high in patients with constrictive pericarditis. DNA PCR for 
Mycobacterium Tuberculosis was   positive in 4 patients (80%) in   the constrictive pericarditis  
group.  Pericardial  biopsy  was  suggestive  of  tuberculous  infection  in  5  patients  (48%)  in 
constrictive pericarditis group and 2 patients (18%)   in cardiac tamponade group. 
We conclude that the most common cause in all the three groups of chronic pericarditis  
was idiopathic.  Hypothyroidism as a cause for chronic pericardial effusion was found in 6 
patients (22%). Chronic renal failure was found in 4 patients (15%) with chronic pericardial 
effusion. Only one patient (4%) in chronic pericardial effusion had tuberculous infection .In 
CCP 5 patients (48%) had tuberculous etiology and the rest (52%) were idiopathic. In cardiac 
Tamponade 2 patients (18%) were found to have tuberculous infection and the remaining 9 
patients (82%) were idiopathic.
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PROFORMA
ETIO - PATHOLOGICAL PROFILE OF CHRONIC PERICARDITIS
NAME: AGE: SEX:
IPNO: CDNO: ADD:
1. Chest Pain Duration:
2. Breathlessness
3. Facial Puffiness And Leg Swelling
4. Fever
5. H/O TB
6. H/O Trauma/Surgery
7. H/O Rheumatic Fever
8. H/O Irradiation
9. H/O MI
10. H/O Renal Failure/Dialysis
11. H/O Drug Intake
12. H/O Hypothyroidism
13. Respiratory Rate
14. Pulse Rate
15. Blood Pressure                               Pulsus Paradoxsus:
16. JVP
17. Heart Sounds
18. Pericardial Knock
19. Pericardial Rub
20. Hepatosplenomegaly
INVESTIGATIONS:
1. HEMOGRAM HB TC DC N L M E B
2. ESR
3. BLOOD SUGAR Urea Creatinine
4. CXR CTR% Calcification     RA   LA   RV     LVApex
              AVGroove  
ECG:
P PR Q QRS ST T QT/QTC OTHERS
AMP
Duran
Axis
AMP
Duran
Axis
ECHO: M MODE :
1. LVIDD : LVIDS : EF:
2. LA Size :
3. Aorta 
4. Calcification
5. Septal Notch
6. Post Wall Movement.
2D ECHO:
MED-LAT SUP-INF
1. LA (MM)
2. RA (MM)
3. Volume (CM3) RA LA
4. RVID (MM)
5. Septal Bounce
DOPPLER :
1. Hepatic Flow
2. Pulmonary Flow
3. Mitral Flow
PERICARDIAL FLUID ANALYSIS :
Volume : Colour :
TC: DC N L E M B
Protein Sugar LDH ADA
Culture Bacterial Fungal TB
DNA PCR
Antibody
PERICARDIAL BIOPSY
Histopathology:
Culture Bacterial TB Fungal DNA PCR
MANAGEMENT :
MEDICAL
1. ATT
2. Steroids
3. NSAIDS
SURGICAL :
1. Window Pericardiectomy
2. Pericardial Resection
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